Joshua Lev Sells 12,000 Shares of electroCore (NASDAQ:ECOR) Stock

electroCore, Inc. (NASDAQ:ECOR) CFO Joshua Lev sold 12,000 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $10.22, for a total value of $122,640.00. Following the transaction, the chief financial officer directly owned 84,889 shares in the company, valued at $867,565.58. The trade was a 12.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

electroCore Trading Down 1.9%

NASDAQ ECOR traded down $0.18 during mid-day trading on Tuesday, hitting $9.47. The company’s stock had a trading volume of 109,294 shares, compared to its average volume of 88,973. The company’s 50 day simple moving average is $7.74 and its 200 day simple moving average is $7.21. electroCore, Inc. has a twelve month low of $4.41 and a twelve month high of $10.95. The firm has a market capitalization of $85.42 million, a price-to-earnings ratio of -5.70 and a beta of 0.93.

electroCore (NASDAQ:ECOR) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.33) earnings per share for the quarter, topping the consensus estimate of ($0.42) by $0.09. electroCore had a negative net margin of 39.96% and a negative return on equity of 1,956.38%. The firm had revenue of $9.45 million for the quarter, compared to the consensus estimate of $9.49 million. As a group, research analysts forecast that electroCore, Inc. will post -1.4 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of electroCore in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $18.00.

Institutional Trading of electroCore

Several institutional investors have recently made changes to their positions in ECOR. Two Sigma Investments LP lifted its position in shares of electroCore by 20.8% during the third quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock valued at $122,000 after purchasing an additional 4,231 shares in the last quarter. Cubist Systematic Strategies LLC bought a new position in shares of electroCore during the 1st quarter worth approximately $153,000. WealthShield Partners LLC bought a new position in shares of electroCore during the 1st quarter worth approximately $157,000. Jane Street Group LLC boosted its stake in shares of electroCore by 114.4% in the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock worth $246,000 after buying an additional 19,599 shares during the last quarter. Finally, DRW Securities LLC purchased a new position in shares of electroCore in the 4th quarter worth approximately $264,000. Institutional investors own 26.74% of the company’s stock.

electroCore Company Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.